Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)
| 2.42 Delayed Data As of 4:00pm ET |  +0.09 / +3.86%Today’s Change | 1.31 Today|||52-Week Range 3.48 | +26.70% Year-to-Date |
Latest LXRX News | Press Releases
No recent news for Lexicon Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.33 |
| Today’s open | 2.34 |
| Day’s range | 2.34 - 2.49 |
| Volume | 9,630 |
| Average volume (3 months) | 399,900 |
| Market cap | $437.8M |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | -2.09% |
| Earnings growth (this year) | -10.00% |
| Earnings growth (next 5 years) | +44.51% |
| Revenue growth (last year) | -53.36% |
| P/E ratio | NM |
| Price/Sales | 2,277.34 |
| Price/Book | 3.67 |
Competitors
Data as of 4:00pm ET, 03/31/2023
Financials
| Next reporting date | May 4, 2023 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $139.0K |
| Annual profit (last year) | -$101.9M |
| Net profit margin | -73,341.01% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters The Woodlands, Texas |
Forecasts
